I rate AbbVie stock as a Strong Buy, based on its FDA approval of Rinvoq. Read the latest analysis on the stock here.
7h
Reliance Q2 Results LIVE: Profit surges 16% YoY; telecom biz ARPU grows to ₹211.4 ahead of Jio IPO
Mukesh Ambani-led Reliance Industries posted a 16% YoY jump in Q2 profit after tax, while revenue saw a 10% growth. Its PAT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback